دورية أكاديمية
Global challenges and policy solutions in breast cancer control.
| العنوان: | Global challenges and policy solutions in breast cancer control. |
|---|---|
| المؤلفون: | Trapani D; European Institute of Oncology, IRCCS, Milan, Italy; Dana-Farber Cancer Institute, Boston, MA, USA., Ginsburg O; International Agency for Research on Cancer, Lyon France., Fadelu T; Dana-Farber Cancer Institute, Boston, MA, USA., Lin NU; Dana-Farber Cancer Institute, Boston, MA, USA., Hassett M; Dana-Farber Cancer Institute, Boston, MA, USA., Ilbawi AM; World Health Organization, Geneva, Switzerland., Anderson BO; World Health Organization, Geneva, Switzerland; Departments of Surgery and Global Health-Medicine, University of Washington, Seattle, Washington, USA., Curigliano G; European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haematology, University of Milan, Milan, Italy. Electronic address: Giuseppe.curigliano@ieo.it. |
| المصدر: | Cancer treatment reviews [Cancer Treat Rev] 2022 Mar; Vol. 104, pp. 102339. Date of Electronic Publication: 2022 Jan 19. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2003- : Amsterdam : Elsevier Original Publication: London, New York, Academic Press. |
| مواضيع طبية MeSH: | Breast Neoplasms*/diagnosis , Breast Neoplasms*/epidemiology , Breast Neoplasms*/therapy, Combined Modality Therapy ; Female ; Global Health ; Health Promotion ; Humans ; Policy ; World Health Organization |
| مستخلص: | Breast cancer is the leading cause of cancer morbidity, disability and mortality in women, worldwide. Overall, in 2020, it was the most diagnosed malignancy. Differences in breast cancer mortality have been historically evidenced, as a result of disparities in access to diagnosis, treatment and palliative care. Epidemiologic trends in the last decades display three main patterns of breast cancer mortality: some high-income countries report continuous substantial improvements exceeding 2% annual mortality reduction; however, many low- and middle-income countries (LMICs) have stagnant or even increasing mortality rates. Population-based studies show that investing in breast cancer control, based on a primary health care approach, and expanding the cancer treatment capacity can portend population health benefits, with positive changes of the epidemiological adverse trajectories. Framed as part of the political commitment to the Sustainable Development Goals Agenda, World Health Organization (WHO) has recently launched a global initiative to tackle disparities in breast cancer mortality. The WHO-led Global Breast Cancer Initiative (GBCI) is framed across 3 pillars, to address key determinants of the cancer-related outcomes: health promotion and early detection, timely access to diagnosis and treatment, comprehensive breast cancer treatment, palliative and survivorship care. GBCI is a systematized approach, with the goal to (i) increase the fraction of newly diagnosed invasive cancers being stage 1 or 2 at diagnosis (60% or more), (ii) ensure diagnostic work-up to be completed within 60 days from the first connection with the primary healthcare providers to avoid delays in diagnosis and treatment and (iii) assure 80% or more women with breast cancer to undergo and complete multimodal treatments. GBCI will pursue a comprehensive and multisectoral approach, to deliver population health, social and economic benefits, ultimately intended as an entry point for health system strengthening and for the broader cancer control. (Copyright © 2022 Elsevier Ltd. All rights reserved.) |
| معلومات مُعتمدة: | 001 International WHO_ World Health Organization |
| فهرسة مساهمة: | Keywords: Breast cancer; Cancer control; Cancer policy; Global breast cancer initiative; Global oncology; World Health Organization |
| تواريخ الأحداث: | Date Created: 20220125 Date Completed: 20220308 Latest Revision: 20220308 |
| رمز التحديث: | 20231215 |
| DOI: | 10.1016/j.ctrv.2022.102339 |
| PMID: | 35074727 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder كن أول من يترك تعليقا!